UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549

                                   FORM 10-KSB

[X]    ANNUAL  REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF  1934
               For  the  fiscal  year  ended  December  31,  1999

[ ]    TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SSECURITIES EXCHANGE
ACT  OF  1934
               For the transition period from                to
                                              --------------   -----------------

               Commission  file  number  000-28545

                          WEBMEDICALSERVICES.COM, INC
                          ---------------------------
                 (NAME OF SMALL BUSINESS ISSUER IN ITS CHARTER)

Nevada                                        88-0418439
------                                        ----------
(State or other jurisdiction of             (I.R.S. Employer Identification No.)
incorporation  or  organization)

9410  Broadview,  Miami,  FL                   33154
----------------------------                   -----
(Address of principal executive offices)      (Zip  Code)

Issuer's  telephone  number  (877)603-4382

         Securities registered under Section 12(b) of the Exchange Act:

Title of each class                    Name of each exchange on which registered
-------------------                    -----------------------------------------
NONE

         Securities registered under Section 12(g) of the Exchange Act:

                               Title of each class
                               -------------------
                         Common Stock, $.0001 par value

     Check  whether  the  issuer  (a)  filed all reports required to be filed by
Section  13  or 15(d) of the Exchange Act during the past 12 months (or for such
shorter  period  that the registrant was required to file such reports), and (2)
has  been  subject  to such filing requirements of the past 90 days.   [X] Yes
[ ] No

     Check  if  there  is no disclosure of delinquent filers in response to Item
405  of  Regulation S-B is not contained in this form, and no disclosure will be
contained,  to  the  best  of  registrant's  knowledge,  in  definitive proxy or
information statements incorporated by reference in Part III of this Form 10-KSB
or  any  amendment  to  this  for  10-KSB  [ ]

State  issuer's  revenues  for  its  most  recent  fiscal  year.
     NONE

     The Company's stock is not, and has not, been traded or quoted.  Therefore,
there  is  no  way  to  ascertain  a  market  value  for  the  stock.

     The  number  of  shares outstanding as of December 31, 1999 was 20,000,000.


<PAGE>
DOCUMENTS  INCORPORATED  BY  REFERENCE
     NONE

     The  following  discussion contains, in addition to historical information,
forward-looking  statements  that involve risks and uncertainties. The Company's
actual  results  could  differ  significantly  from the results discussed in the
forward-looking  statements.  Factors  that  could  cause  or contribute to such
differences  include,  but are not limited to, those discussed below and in Item
7,  "Management's  Discussion  and  Analysis  of  Financial  Condition."

                                     PART I
Item  I  DESCRIPTION  OF  BUSINESS

A.     BUSINESS  DEVELOPMENT  AND  SUMMARY

     WebMedicalServices.com,  Inc.,  hereinafter referred to as "The Company" or
WebMedical,  was  organized  by the filing of articles of incorporation with the
Secretary of State of the State of Nevada on February 16, 1999.  The articles of
The  Company  authorized  the  issuance  of fifty million (50,000,000) shares of
Common  Stock  at  a  par  value  of  $0.0001  per  share.

     The  Company  is  a developmental stage company with the principal business
objective  to  provide  medical  services  and  products  to the public over the
Internet.  It  is  intended  for  the public to be able to receive consultations
from  physicians by typing in questions with the on-line site; also by telephone
over  a "900" number, fax, or mail.  Payment may be by credit card over a secure
website  or  with a toll free "800" telephone or check by fax.  Patients may pay
for  individual  consultations  or  subscribe  to  a  yearly  flat payment plan.
Management  intends  to  provide patients with access to primary care physicians
over  the  Internet in family medicine, pediatrics, internal medicine, including
cardiology  and  obstetrics/gynecology.

     The  Company plans to sell and construct websites to physicians, giving the
physicians an exclusivity in various geographic areas.  The cost of constructing
a  site  for  a  physician  could  range  between  five hundred to five thousand
dollars,  depending on the complexity of the site.  Initially, the Company plans
to  concentrate  on  primary  care  physicians  such as family medicine.  Later,
specialties  such  as  psychiatry, surgery, ear-nose-throat, urology, neurology,
endocrinology  (including  diabetes),  oncology  (cancer),  rheumatology  may be
added.  The Company expects that information about holistic alternative medicine
and  products  will  be popular as a site.  Physicians trained in this field may
also  have  a  network  of  sites  developed  by  the  Company.

     Direct selling to the public of medial supplies, products, herbal medicines
and  over-the-counter  non-prescription medicines are planned to be available at
the  site.  Easy  diagnostics e.g.:  glucose monitoring, cholesterol tests, AIDS
testing, pregnancy tests, urine test strips, ear, axillary, pacifier and digital
thermometers,  ace  bandages,  splints,  blood  pressure  cuffs,  otoscopes,
anti-poison  kits,  nebulizer  machines  for asthmatics, emergency and first aid
kits,  diaper  disposals, special feeding bottles are among some of the products
that  are  planned.

     The  Company  also  plans  to develop computer software, tentatively called
"Smart  Kids"  to  assist  parents  in  teaching babies and young children early
motor,  language,  math,  science  and  reading  skills.

     The  Company  also  plans to assist in physician recruitment and continuous
medical  education  courses  (CME)  to physicians over the Internet to help them
renew  their  licenses.  Physicians  looking  for  job  placements  are a sudden
growing industry as a result of managed care, management believes.  In addition,
discount  travel  services,  insurance,  office  supplies and auto leases can be
offered  to  physicians  via  the  Internet.


<PAGE>
     In  addition,  the  Company  plans  to  purchase and manage primary medical
practices  (pediatrics,  family  medicine  and  internal medicine) and will also
concentrate  efforts  to  acquire  specialty  practices  outside of managed care
(e.g.:  plastic  surgery,  ophthalmology  including laser refractive eye surgery
and  dermatology,  including  cosmetic procedures).  The Company also intends to
assist  in  the  sale of medical practices to large medical management companies
and  hospitals.

     The  Company  has  no  website  as  yet,  and  has  not realized any of its
intentions  as  yet.  The  Company  anticipates 6 to 9 months until the research
phase  is  completed,  and  development  of its website(s) can begin in order to
begin  phase  II,  when actual physicians will be contacted and revenues will be
expected.

     The  Company  intends  to focus on achieving and maintaining profitability,
also ensuring tight financial and systems control by 1) being fully prepared for
the  possible  onslaught  of  "hits"  to  its website, while still providing top
quality customer service, 2) focusing on quality, not quantity, of new staff, 3)
instituting financial/accounting software systems to enable tight cash flow, and
minimizing  long-term  contractual  arrangements  with  suppliers.

B.     PRINCIPAL  PRODUCTS  AND  SERVICES  AND  PRINCIPAL  MARKETS

OVERVIEW

     WebMedical has the principal objective to become a leading medical resource
on the Internet on an international scale.  The Company plans to target the U.S.
market  as  well  as  overseas,  South  America,  and  other  foreign  venues.

STRATEGY

     The  Company  plans  to  use  its vast knowledge of the medical industry to
provide services/products over the Internet to two principal markets:  consumers
and  physicians.  By  combining  the need for medical services/products with the
Internet,  the  Company  plans  to  expand its normal target market from a small
geographical  area  to  the  international  sector.

C.  DISTRIBUTION  METHODS  OF  THE  PRODUCTS  OR  SERVICES

     A)   Distribution:

                    The Company plans to ship its products to the consumer after
payment is received.  Information/opinions will be disseminated on the Internet.
The  Company  believes  the  website  will  also  provide  an audience for other
revenue-making  projects, such as banners, affiliate sales and related products.

     B)   Advertising  and  Promotion

               The Company plans to attract physicians to its site(s) with sales
literature,  and  direct  mail.  Multi-faceted  advertising  for the consumer is
being  planned,  with  an  emphasis  on  the  Spanish-speaking  market.

     C)   Customer  Service

               The  Company  recognizes the need for an effective and responsive
customer  service  base.  Using its planned website, the Company is developing a
customer  service  strategy  to  include  a  help  section  on  the Internet for
immediate  response  to  its  customers, as wells as chat rooms for users of its
products  on  a  24-hour  basis.


<PAGE>
D.  GOVERNMENTAL  APPROVAL,  REGULATION  AND  ENVIRONMENTAL  COMPLIANCE

        Other  than  general  business  licensing  requirements,  management  is
unaware  of  any governmental approval necessary for the Company's operations in
the  medical  industry  via  the Internet. In addition, management is unaware of
existing  or  probable  governmental  regulations  on the medical industry as it
refers to the Internet. Management anticipates no material costs associated with
compliance  with  either  federal,  state  or  local  environmental  law.

        However,  most  healthcare businesses  are  subject to extensive federal
and  state  government  regulations.  The  laws  and  regulations  applicable to
financial arrangements in the healthcare industry are complex and may be subject
to  varying  interpretations.  The  Company  intends to comply with all laws and
regulations  to which its businesses may be subject.  There can be no assurance,
however,  that changes to current laws or regulations or that existing or future
administrative or judicial interpretations of such laws and regulations will not
affect  the  Company's  businesses.

        There  are  no  current federal, state or local laws, statutes, or rules
regulating the Internet at this time that would affect the Company.  However, if
new  enactments  were  to become effective, depending on the scope and extent of
such  laws/regulations,  the Company could be directly affected either adversely
or  beneficially.

E.  EMPLOYEES

        As of  the  current date, the Company has no paid employees. The Company
is  dependent  on  Burton  Feinerman,  President. Dr. Feinerman does not plan to
spend  full time efforts on the research and development of products, plans, and
physicians  during  the  first  six  months  of  operation. Once these plans are
formulated,  the  Company  will  need to hire full time operational staff as its
operations  commence.  Dr.  Feinerman  is  fully  prepared  to  devote full time
efforts  at  that  time,  but  there  can  be  no assurance that other full time
employment  of Dr. Feinerman  would not offer a better salary and package to Dr.
Feinerman  and  Dr.  Feinerman  could  abandon the Company. The Company's future
success  also  depends  on  its  ability  to  attract and retain other qualified
personnel,  for  which  competition is intense. The loss of Dr. Feinerman or the
Company's  inability  to attract and retain other qualified employees could have
material  adverse  affect  on  the  Company.

F.  COMPETITION

        The  Company  competes  with  numerous  other  healthcare  and  Internet
companies.  Many  of these competitors have substantially greater resources than
WebMedical.  The  Company  has identified a niche in the market as it relates to
medical  products  and  services,  and  hopes to capitalize on the advent of the
Internet.

G.  DEVELOPING  AND  CHANGING  MARKET

        The  market  conditions  for  healthcare  and  products  are continually
evolving and changing. The Company believes the current conditions will continue
favorably for this type of venture. There can be no assurance that the Company's
assessment of the situation is correct, nor that the products it selects will be
accepted  by  the  consumers.

ITEM  2.  DESCRIPTION  OF  PROPERTY

        The  Company  currently  pays  no rent for its executive offices. Office
space  is  currently being used at the home of Dr. Burton Feinerman. This office
arrangement  is considered adequate for current and short-term operations of the
Company.


<PAGE>
ITEM  3.  LEGAL  PROCEEDINGS.

        The  Company  is  not  presently  a  party to any litigation, nor to the
knowledge  of management is any litigation threatened against the Company, which
would  materially  affect  the  Company.

ITEM  4.  SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS.

          Not  applicable

                                     PART II

ITEM  5.  MARKET  FOR  COMMON  EQUITY  AND  RELATED  STOCKHOLDER  MATTERS.

        The  Company's  shares  of Common Stock are not registered with the U.S.
Securities  and Exchange Commission under the Securities Act of 1933, as amended
(hereinafter  referred  to  as the "Act"), and certain shares issued pursuant to
Regulation  D-504,  are  "restricted  securities."

        Since  its  inception  February  16, 1999, the Company has not paid cash
dividends  on  its  Common Stock. It is the present policy of the Company not to
pay  cash  dividends  and  to  retain  future  earnings to support the Company's
growth.  Any  payments  of  cash dividends in the future will be dependent upon,
among  other  things,  the  amount  of  funds available therefore, the Company's
earnings, financial condition, capital requirements, and other factors which the
Board  of  Directors  deem  relevant.

As  of  December  31,  1999,  there  were  35  Common  Shareholders  of  record.

The transfer agent for common stock is Florida Atlantic Stock Transfer, 7130 Nob
Hill  Road,  Tamarac,  Florida  33321.

ITEM  6.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OR  PLAN  OF  OPERATION.

     The  following  discussion  should  be  read  in  conjunction  with, and is
qualified  in  its  entirety by the Financial Statements section included below.

     With  the exception of historical matters, the matters discussed herein are
forward looking statements that involve risks and uncertainties. Forward looking
statements  include,  but  are not limited to, statements concerning anticipated
trends in revenues and net income, the date of introduction or completion of the
Company's  products,  projections concerning operations and available cash flow.
The  Company's actual results could differ materially from the results discussed
in  such  forward-looking  statements. The following discussion of the Company's
financial condition and results of operations should be read in conjunction with
the  Company's  financial  statements  and  the  related notes thereto appearing
elsewhere  herein.

A.  OVERVIEW

     (1)  The  Company,  since  raising its initial capital, has concentrated on
researching  and  developing  medical  products/services  via the Internet.  The
Company is formulating its plans for introduction of its planned products on the
Internet,  as well as its marketing strategies.  The Company has also identified
potential  employees for the development of its products, and continued service.

     During  the  initial  phase  of  researching  and  developing,  the Company
anticipates  the  need  for  additional  capital  for  equipment, personnel, and
offices.  Its current office at the home of its President, Dr. Burton Feinerman,
9410  Broadview,  Miami,  FL  33154,  is being used free of charge and should be
adequate  for  the  next  few  months,  as  research  and  plans are formulated.


<PAGE>
     On  June  17,  1999,  the  Company  completed  an  offering  of  2,000,000
shares  of  the  Common  Stock  of  the Company to approximately 34 unaffiliated
shareholders.  This  offering  was  made  in reliance upon an exemption from the
registration  provisions  of  Section  4(2)  of  the Securities Act of 1933 (the
"Act"),  as  amended,  pursuant to Regulation D, Rule 504 of the Act.  As of the
date  of  this  filing,  the  Company has approximately 20,000,000 shares of its
$0.0001  par value common voting stock issued and outstanding, which are held by
35  shareholders of record.  Management fully anticipates that the proceeds from
the  sale  will be sufficient to provide for the Company's capital needs for the
next  approximately  three  (3)  to six (6) months, during its research stage of
development.

     In  addition,  management  of the Company believes the needs for additional
capital  going  forward  will  be  derived  somewhat  from internal revenues and
earnings  generated  from  the  sale  of  its  products  and  services.  If  the
Company  is  unable to begin to generate revenues from its anticipated products,
management  believes the Company will need to raise additional funds to meet its
cash  requirements.

     The  Company believes that its initial revenues will be primarily dependent
upon  the  number of physicians it can attract, the quality of its software, the
professionalism  of  its  customer  service  plan, and the profit margins on the
products  it  offers. Realization of significant sales of the Company's products
and  services  during  the  fiscal year ending December 31, 2000 is vital to its
plan  of  operations.  To  that  end,  realization of developing quality medical
website(s)  and  selling  its  products to the target market is paramount to its
plan.

(2)     No  engineering,  management  or  similar  report  has  been prepared or
provided  for  external  use  by the Company in connection with the offer of its
securities  to  the  public.

(3)     Management believes that the Company's future growth and success will be
largely  dependent  on  its ability to obtain physicians to use its websites, to
attract  a  stable  medical  force,  to  develop quality software, to market and
advertise  effectively  and  efficiently, and its choice of profitable products.

        The  Company  has  incurred a minimal amount in research and development
costs from February 16,  1999,  to  present,  and the Company does not expect to
incur any significant research and development  expenses  during the fiscal year
ending December  31,  2000.

(4)     The  Company  expects to purchase regular office equipment, i.e., desks,
calculators,  computers  within the next 12 months.  The Company also intends to
purchase/lease  adequate  computer  equipment  for  storage  and  information
dissemination  via the Internet for its products and services.  The Company does
not  have  any  facilities  or  equipment  to  sell  at  this  time.

(5)     Management  anticipates  that it will hire and add 5 full time employees
over the next twelve (12) months, as well as a medical staff, which will be paid
on  a  commission-only  basis.  Employees  will not be added during Phase I, the
research  period.  Employees  will  be  added  as  revenues  permit.

(6)     From inception in February 1999 through present, the Company has devoted
a  majority  of  its  time  on  research  and development. During this time, the
Company incurred start up costs of $55,000 of which $45,000 has been paid by Dr.
Burton  Feinerman,  individually.  This  cost  included  all  start  up costs of
attorney,  filing  fees,  and  accountants,  as  well as advisory and consulting
services.  This  $55,000 start up costs is borne solely by Dr. Burton Feinerman,
and  is  part  of  his  contribution  to  the Company, for which he has received
18,000,000  shares  in  the  Company,  constituting  a 90% controlling position.


<PAGE>
B.  SEGMENT  DATA

     There  were  no  revenues from sales since its inception February 16, 1999.
Because  there  was no revenue, no table showing percentage breakdown of revenue
by  business  segment  or  products/service  line  is  included.

C.  RESULTS  OF  OPERATIONS

     There  were no revenues from sales up to the date of this filing. Since its
inception,  February 16, 1999, the Company has formed the Company's organization
to  pursue  its  business  strategy.

     a)  Pre-Operating  Expenses.  Pre-Operating expenses were not necessary, as
all  costs  for  the Company's legal organization, legal expenses. and financial
audits  are  included  in  the  start of costs of $55,000, to be paid in full by
Burton  Feinerman,  individually.

     b)  Revenues.  The  Company is a development state enterprise as defined in
SFAS  #7,  and  has  yet  to  generate  any  revenues.  The  Company is devoting
substantially  all of its present efforts to: (1) develop materials and products
to  attract  physicians  and  consumer,  (2)  develop plans of operations (sales
strategies,  customer service, e-commerce), and (3) obtain sufficient capital to
commence  full  operations.

Impact  of  Year  2000  Issue

The  Company  has  not experienced any adverse effect of Year 2000 issues on its
systems  or  operations, or the systems or operations of its customers and trade
suppliers.

D.  LIQUIDITY  AND  CAPITAL  RESOURCES

     As  of the date of this filing, the Company has $44 on hand or in the bank.
Until  such  time  as  the  Company sets forth and implements its business plan,
there  will  he  no  need  for additional capital, since Dr. Burton Feinerman is
contributing  his  time  and  expenses at no cost during that time. Although the
complete  strategic  business  plan  has  not  yet been fully researched and put
together,  management, at present, foresees the possibility of the need to raise
about  $500,000  in  additional  capital to fully enter the revenue stage of its
plan.

     The  receipt  of  funds from Private Placement Offerings and loans obtained
through  private  sources  by  the Company are a possibility to fund the Company
until  revenues  can be achieved.  Since inception, the Company has financed its
cash flow requirements though issuance of common stock and through contributions
from  Burton Feinerman.  As the Company expands its activities, it may  continue
to  experience net negative cash flows from operations, pending receipt of sales
revenues.  Additionally  the  Company  may  be  required  to  obtain  additional
financing to fund operations through Common Stock offerings and bank borrowings,
to  the  extent  available,  or  to  obtain  additional  financing to the extent
necessary  to  augment  its  working  capital.

     Over  the  next twelve months, the Company intends to initiate its revenues
by  establishing  a  website  for  e-commerce  and contracting  with physicians.
However,  the  Company  will  continue  the  research  and  development  of
clients/products  and in-depth plans. The Company believes that existing capital
and  anticipated  funds from operations will be sufficient to sustain operations
and planned expansion in the next three (3) to six (6) months. However, the need
for  additional  capital  after  that  time  may be necessary. Consequently, the
Company  may seek additional financing in order to sustain operations. There can
be  no  assurance such additional funds will be available or that, if available,
such  additional  funds  will  be  on terms acceptable to the Company. In either
case,  the  financing  could have negative impact on the financial conditions of
the  Company  and  its  Shareholders.


<PAGE>
     The  Company  anticipates  that  it  will  incur  operating  losses  in the
next  twelve months. The Company's lack of operating history make predictions of
future operating results difficult to ascertain. The Company's prospects must be
considered  in  light  of  the  risks,  expenses  and  difficulties  frequently
encountered  by  companies  in  their  early  stage of development, particularly
companies  in  new  and  rapidly  evolving  markets.  Such risks for the Company
include,  but  are  not limited to, an evolving and unpredictable business model
and  the  management  of growth. To address these risks, the Company must, among
other  things,  obtain  a  customer base, implement and successfully execute its
business  and  marketing strategy, continue to develop its website and products,
provide superior customer services and order fulfillment, respond to competitive
developments, and attract, retain and motivate qualified personnel. There can be
no  assurance  that the Company will be successful in addressing such risks, and
the  failure  to  do  so  can  have  a  material adverse effect on the Company's
business  prospects,  financial  condition  and  results  of  operations.

     Initial  financing  is  only  to  provide  funds  to  prove the business be
necessary to provide  medical products/services to consumers and physicians  via
the Internet.  The  Company  hopes to enter into additional funding arrangements
through  strategic  partnerships,  merger,  equity  offering  or  debt offering.
Nothing has been  secured  as  of  this  time.

E.  RISKS  ASSOCIATED  WITH  OPERATIONS

     The  Company's  long-term  success  is  partially  predicated  on  the
marketability  of  its  website and products and the strength of its physicians.

     Its principal competition consists of entities within the medical industry,
which are well established.  The Company's ability to compete against these more
established and more financially stable companies is premised upon the Company's
ability  to  initiate  and  fulfill  its  development  plans.

     Another  uncertainty  is  the  dependence  on  key  personnel familiar with
the  control,  administration,  development,  and training of the physicians and
website  developers.  The  loss  of  Burton  Feinerman, President, could have an
adverse  effect  on  its  continued  operations.

     Although  research  in  the  Company  indicates  that  the  Internet  will
continue  with  little,  if any regulation, and will continue to become a viable
marketing  tool, there can be no assurances that the Internet will prove to be a
profitable  outlay  for  the  Company  in  its  business  plans.

     While  the  Company's  plan  is  being researched and developed thoroughly,
there  is  no assurance the plan will be accepted in or by the marketplace, nor,
that  if  it  is  accepted,  that  demand will be sufficient to make the Company
profitable.  The  Company  cannot  project  with  certainty  the  outcome of its
operations, and there are no assurances that the Company will operate profitably
in  either  the  near  or  long  term.

     Local,  national,  and  international  economic  conditions  may  have  a
substantial  adverse  affect  on  the efforts of the Company. The Company cannot
guarantee  against  the  possible  eventuality of any potential adverse economic
conditions.

ITEM  7.  FINANCIAL  STATEMENTS.

          The  financial  statements  follow  Item  13  of  this  report.


<PAGE>
ITEM  8.  CHANGES  IN  AND  DISAGREEMENTS  WITH  ACCOUNTANTS  ON  ACCOUNTING AND
          FINANCIAL  DISCLOSURE.

          NONE

                                    PART III

ITEM  9.  DIRECTORS,  EXECUTIVE  OFFICERS,  PROMOTERS  AND  CONTROL  PERSONS;
          COMPLIANCE  WITH  SECTION  16(A)  OF  THE  EXCHANGE  ACT.

     The  following  table  sets forth the names, positions with the Company and
ages  of  the executive officers and directors of the Company. Directors will be
elected  at  the Company's annual meeting of shareholders and serve for one year
or  until  their successors are elected and qualify. Officers are elected by the
Board,  and  their  terms  of  office  are,  except  to  the  extent governed by
employment  contract,  at  the  discretion  of  the  Board.

Name                     Age            Title
----                     ---            -----
Dr. Burton Feinerman     70        President, Chairman

Duties, Responsibilities and Experience

BURTON FEINERMAN, M.D., PRESIDENT

     B.A.  New  York  University;  M.D.  New York Medical College; post graduate
training  at  the  Mayo  Clinic,  Rochester,  Minnesota;  Board Certified by the
American  Board  of  Pediatrics;  served  in  U.S.  Army  in Germany as Chief of
Pediatrics,  98th General Hospital; Former Chief of Pediatrics, Parkway Regional
Hospital,  International  Hospital,  Miami  General  Hospital,  Humana  Hospital
Biscayne  in  Miami,  Florida;  Chief Executive Officer of Opa-General Hospital;
Former  Chairman,  Cancer  Technology,  Inc.;  Administrator,  Town  and Country
Medical  Center,  Board  of  Directors,  Institute  for  Advanced  Studies  in
Immunology,  George  Washington  University  School  of  medicine;  former
Vice-President  Hainlin  Mill  Land Development Company; President, Kids Medical
Services  International.

     From  1960  to  1994,  Dr.  Feinerman  had  a  pediatric practice in Miami,
Florida,  that  was  generating $1.8 million/annum in revenue at the time of its
sale.  He subsequently had a successful practice in Key Largo, Florida from 1994
to  1997  that  he  sold to a large hospital.  Member of the Board of Directors,
Internet  Application  Services  Institute,  LatinMD.com,  Inc.  and
Chinawebmedical.com,  Inc.

Notable  achievements  in  his  career  and  include:

-     Alumnus  of  The  Year,  1980  at  New  York  Medical College in Education
-     Pioneer  researcher  in  cancer  immunology  and  immunotherapy
-     Pioneer  in  pediatric  managed  medical  care
-     Active  in  many  business  and  Internet  organizations

Strengths  and  personality:

-     Creativity:  Pioneer  in  many  medial  fields;  early  developer  1994 in
      Internet  sites;  able  to  generate  new  concepts  ahead  of  the  times
-     Administration:  Organization  skills in the business world and e-commerce


<PAGE>
-     Development:  Organizes  good  management  teams  that  are  functional,
      practical  and  imaginative
-     Flexibility:  Able  to  make  necessary  changes  and  go  in  different
      directions  as  the  situations  may  demand
-     Hard Working:  Self-described "workaholic", 18-hour days, 7 days a week to
      get  a  job  done.

ITEM  10.  EXECUTIVE  COMPENSATION.

     Dr.  Burton Feinerman has not received, nor is he projected to receive, any
compensation  for  his  services,  including  his  capacities  as  Chairman  and
President  other than the issuance of the Company's Common Stock as set forth in
Item  4  above.

     Should  the  Company  become profitable and produce commensurate cash flows
from  operations  and/or through the sale of strategic investments, there may be
some  level  of  compensation  paid  to  him.  However,  this will be subject to
approval  by  the  Company's Board of Directors. It is the responsibility of the
Company's  Officers  and  its  Board of Directors to determine the timing of any
remuneration  for  key  personnel. Such determination and timing thereof will be
based upon such factors as positive cash flow to include equity sales, operating
cash  flows, capital requirements, and a positive cash flow balance in excess of
$12,500  per  month. At the time cash flow reaches this point, and appears to be
sustainable,  the  Officers  and  Board  of  Directors  will again readdress the
compensation  of its key personnel and set forth a more formal and complete plan
for  remuneration  in  line  with  operations  of  the  Company. At present, the
Company's  management  cannot  accurately  estimate  the point when revenues and
operating  cash  flows  will be sufficient enough to implement this compensation
plan,  nor  are  they  able to estimate the exact amount of compensation at this
time.

     There  are  no  annuity,  pension,  or  retirement  benefits proposed to be
paid  of  Officers,  Directors,  or  employees  of  the  Company in the event of
retirement  at  normal  date pursuant to any presently existing plan provided or
contributed  to  by  the  Company,  or  any  of  its  subsidiaries,  if  any.

KEY  OFFICER  EMPLOYMENT  AGREEMENTS

     No  employment  contracts  have been negotiated or signed as yet.  However,
the  Company  plans  on  having  all  key employees and officers sign a detailed
employment  contract  as  appropriate.

COMPENSATION  OF  DIRECTORS

     All  directors  will be reimbursed for expenses incurred in attending Board
or  committee  meetings.

STOCK  OPTION  PLAN  AND  NON-EMPLOYEE  DIRECTORS'  PLAN

     No  stock  option  plan  has been set forth, and no non-employee directors'
plan has been instituted.  The Company may decide, at a later date, and reserves
the  right  to,  initiate  these  plans  as  deemed  necessary  by  the  Board.

ITEM  11.  SECURITY  OWNERSHIP  OF  CERTAIN  BENEFICIAL  OWNERS  AND MANAGEMENT.

     The following table sets forth certain information as of December 31, 1999,
with  respect to the beneficial ownership of Common Stock by (i) each person who
to  the knowledge of the Company, beneficially owned or had the right to acquire
more  than 5% of the Outstanding Common Stock, (ii) each director of the Company
and  (iii)  all  executive  offices  and  directors  of  the Company as a group.


<PAGE>
Name of Beneficial Owner (I)             Number        Percent
                                         of Shares     of Class (2)

Dr. Burton Feinerman(3)                  18,000,000      90%
9410 Broadview
Miami, FL 33154

All Directors & Officers as a Group      18,000,000

     (1)  As  used  in  this  table,  "beneficial  ownership"  means the sole or
          shared  power  to vote, or to direct the voting of, a security, or the
          sole or shared investment  power with respect to a security (i.e., the
          power to dispose of, or  to direct the disposition of, a security). In
          addition, for purposes of this  table,  a person is deemed, as of  any
          date, to have "beneficial ownership" of  any security that such person
          has the right to acquire within 60 days after such  date.
     (2)  Figures  are  rounded  to  the  nearest  percentage.
     (3)  As part of  an advisory and servicing agreement, J. Thomas Howard, LTD
          retains  all  voting  rights of the 18,000,000 shares until the fee of
          $55,000 has been  paid  in  full.  As of December 31, 1999, $10,000 is
          still due and payable from  Dr.  Burton  Feinerman,  individually.

ITEM  12.  CERTAIN  RELATIONSHIPS  AND  RELATED  TRANSACTIONS.

     Business  Consultants.  The  Company has relied on J. Thomas Howard, LTD as
key  business  consultants while in its development stage. J. Thomas Howard, LTD
has  provided  the  assistance  in  preparing  the Company to become a reporting
company.  For this assistance, the Company has issued 1,300,000 shares of Common
Stock  at  $.001  per share to companies under control by J. Thomas Howard, LTD.

ITEM  13.  EXHIBITS  AND  REPORTS  ON  FORM  8-K.

          Not  applicable.


                                    PART F/S


<PAGE>
                          WEBMEDICALSERVICES.COM, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                              FINANCIAL STATEMENTS



                                DECEMBER 31, 1999





                              WILLIAMS & WEBSTER PS
                          CERTIFIED PUBLIC ACCOUNTANTS
                            SEAFIRST FINANCIAL CENTER
                           W 601 RIVERSIDE, SUITE 1940
                                SPOKANE, WA 99201
                                 (509) 838-5111


<PAGE>
                          WEBMEDICALSERVICES.COM, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                                TABLE OF CONTENTS


INDEPENDENT  AUDITOR'S  REPORT                                        1

FINANCIAL  STATEMENTS

     Balance  Sheet                                                   2

     Statement  of  Operations                                        3

     Statement  of  Stockholders' Equity                              4

     Statement  of  Cash  Flows                                       5

NOTES  TO  FINANCIAL  STATEMENTS                                      6


<PAGE>
Board  of  Directors
WebMedicalServices.com,  Inc.
9410  Broadview  Drive
Miami,  FL  33154

                          Independent Auditor's Report

We  have  audited the accompanying balance sheet of WebMedicalServices.com, Inc.
(a development stage company) as of December 31, 1999 and the related statements
of operations, cash flows, and stockholders' equity for the period from February
16,  1999 (inception) through December 31, 1999.  These financial statements are
the  responsibility  of  the  Company's  management.  Our  responsibility  is to
express  an  opinion  on  these  financial  statements  based  on  our  audit.

We conducted our audit in accordance with generally accepted auditing standards.
Those  standards require that we plan and perform the audit to obtain reasonable
assurance  about  whether  the  financial  statements  are  free  of  material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing  the  accounting  principles  used  and  significant estimates made by
management,  as well as evaluating the overall financial statement presentation.
We  believe  that  our  audit  provides  a  reasonable  basis  for  our opinion.

In  our  opinion,  the financial statements referred to above present fairly, in
all material respects, the financial position of WebMedicalServices.com, Inc. as
of  December  31, 1999, and the results of its operations and its cash flows for
the  period  from  February  16,  1999  (inception)  to  December  31,  1999, in
conformity  with  generally  accepted  accounting  principles.

As  discussed in Note 2, the Company has been in the development stage since its
inception  and  has no revenues.  The Company's continued viability is dependent
upon  the  Company's  ability  to meet its future financing requirements and the
success  of  future  operations. These factors raise substantial doubt about the
Company's  ability to continue as a going concern.  Management's plans regarding
those  matters are described in Note 2.  The financial statements do not include
any  adjustments  that  might  result  from  the  outcome  of  this uncertainty.



/s/ Williams  &  Webster,  P.S.
Certified  Public  Accountants
Spokane,  Washington
April  5,  2000


<PAGE>
<TABLE>
<CAPTION>
                              WEBMEDICALSERVICES.COM, INC.
                             (A DEVELOPMENT STAGE COMPANY)
                                      BALANCE SHEET


                                                                        December 31,
A S S E T S                                                                 1999
                                                                     ------------------
<S>                                                                  <C>
  CURRENT ASSETS
    Cash                                                             $              44
    Receivable from shareholder                                                 10,000
                                                                     ------------------
      TOTAL CURRENT ASSETS                                                      10,044
                                                                     ------------------


    TOTAL ASSETS                                                     $          10,044
                                                                     ==================

L I A B I L I T I E S   &   S T O C K H O L D E R S '   E Q U I T Y

  TOTAL CURRENT LIABILITIES                                          $               -
                                                                     ------------------

  TOTAL LIABILITIES                                                                  -
                                                                     ------------------

  COMMITMENTS AND CONTINGENCIES                                                      -
                                                                     ------------------

  STOCKHOLDER'S EQUITY
    Common stock, 50,000,000 shares authorized,
      $.0001 par value; 20,000,000 shares
      issued and outstanding                                                     2,000
    Additional paid-in capital                                                  60,089
    Accumulated deficit                                                        (52,045)
                                                                     ------------------
    TOTAL STOCKHOLDERS' EQUITY                                                  10,044
                                                                     ------------------

    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                       $          10,044
                                                                     ==================
</TABLE>

      The accompanying notes are an integral part of these financial statements.


                                        2
<PAGE>
<TABLE>
<CAPTION>
                                       WEBMEDICALSERVICES.COM, INC.
                                       (A DEVELOPMENT STAGE COMPANY)
                                          STATEMENT OF OPERATIONS


                                                      Period From
                                                   February 16, 1999
                                                  (Inception) Through
                                                   December 31, 1999
                                                  -------------------
<S>                                               <C>

R E V E N U E S                                                 -
                                                  ----------------

E X P E N S E S
  Professional services                                    52,045
                                                 -----------------
    TOTAL OPERATING EXPENSES                               52,045
                                                 -----------------

NET LOSS                                                  (52,045)
                                                 =================



  Basic and diluted net loss per common share    $     NIL
                                                 =================

  Weighted average number of basic and diluted
    common stock shares outstanding                    20,000,000
                                                 =================
</TABLE>

      The accompanying notes are an integral part of these financial statements.


                                        3
<PAGE>
<TABLE>
<CAPTION>
                                                  WEBMEDICALSERVICES.COM, INC.
                                                 (A DEVELOPMENT STAGE COMPANY)
                                               STATEMENT OF STOCKHOLDERS' EQUITY


                                                   Common Stock
                                             -----------------------                                     Total
                                               Number                   Additional      Accumulated   Stockholders'
                                             of Shares      Amount    Paid-in Capital     Deficit        Equity
                                             ----------  -----------  ---------------  -------------  -------------
<S>                                          <C>         <C>          <C>               <C>           <C>
Issuance of common stock in June 1999
  for cash at an average of $.004 per share   2,000,000  $       200  $         6,889   $         -   $      7,089

Issuance of common stock at $.003 for
  professional services paid directly by
  the president of the Company               18,000,000        1,800           53,200             -         55,000

Loss for period ending, December 31, 1999             -            -                -       (52,045)       (52,045)
                                             ----------  -----------  ----------------  ------------  -------------
  Balance at December 31, 1999               20,000,000  $     2,000  $        60,089   $   (52,045)  $     10,044
                                             ==========  ===========  ================  ============  =============
</TABLE>

      The accompanying notes are an integral part of these financial statements.


                                        4
<PAGE>
<TABLE>
<CAPTION>
                                WEBMEDICALSERVICES.COM, INC.
                               (A DEVELOPMENT STAGE COMPANY)
                                   STATEMENT OF CASH FLOWS


                                                                Period From
                                                             February 16, 1999
                                                            (Inception) Through
                                                             December 31, 1999
                                                            -------------------
<S>                                                         <C>
Cash flows from operating activities:
  Net loss                                                  $          (52,045)
  Direct payments for professional services by stockholder              45,000
                                                            -------------------

  Net cash used in operating activities                                 (7,045)
                                                            -------------------

Cash flows from investing activities:                                        -
                                                            -------------------

Cash flows from financing activities:
  Issuance of stock                                                      7,089
                                                            -------------------

  Net cash provided by financing activities                              7,089
                                                            -------------------

Net increase in cash                                                        44


Cash, beginning of period                                                    -
                                                            -------------------

Cash, end of period                                                         44
                                                            ===================

SUPPLEMENTAL DISCLOSURES:
  Cash paid for interest and income taxes:
    Interest                                                                 -
                                                            ===================
    Income taxes                                                             -
                                                            ===================

NON-CASH INVESTING AND FINANCING ACTIVITIES
  Professional services paid directly by stockholder                    45,000
                                                            ===================
</TABLE>

      The accompanying notes are an integral part of these financial statements.


                                        5
<PAGE>
                          WEBMEDICALSERVICES.COM, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                        NOTES TO THE FINANCIAL STATEMENTS
                                DECEMBER 31, 1999

NOTE  1 - ORGANIZATION  AND  DESCRIPTION  OF  BUSINESS

WebMedicalServices.com,  Inc.,  (hereinafter "the Company"), was incorporated in
February 1999 under the laws of the State of Nevada primarily for the purpose of
providing  medical  services and non-prescription products to the public via the
internet.  The  Company  also  plans  to design and sell websites to physicians,
giving  the  physicians  exclusivity in various geographic regions.  At December
31,  1999,  the  Company  is  operating  from  the  residence  of  the Company's
president, in Miami, Florida.  The Company is expected to secure separate office
space  in  the  near  future.

The  Company  is  in  the  development stage and as of December 31, 1999 had not
realized  any  significant  revenues  from  its  planned  operations.

NOTE  2 - SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES

This  summary of significant accounting policies of WebMedicalServices.com, Inc.
is presented to assist in understanding the Company's financial statements.  The
financial  statements  and notes are representations of the Company's management
which  is  responsible  for  their  integrity and objectivity.  These accounting
policies  conform  to  generally  accepted  accounting  principles and have been
consistently  applied  in  the  preparation  of  the  financial  statements.

Development  Stage  Activities
------------------------------

The  Company  has  been in the development stage since its formation on February
16,  1999.  It  is  primarily engaged in providing medical services and products
and  designing  and  selling  websites  to  physicians.

Going  Concern
--------------

The  accompanying  financial  statements  have  been  prepared assuming that the
Company  will  continue  as  a  going  concern.

As  shown in the accompanying financial statements, the Company has generated no
revenues  since inception.  The Company, being a developmental stage enterprise,
is  currently  putting  technology  in place which will, if successful, mitigate
these  factors  which  raise  substantial  doubt  about the Company's ability to
continue  as  a  going  concern.  The  financial  statements  do not include any
adjustments  relating  to  the  recoverability  and  classification  of recorded
assets, or the amounts and classification of liabilities that might be necessary
in  the  event  the  Company  cannot  continue  in  existence.

Management intends to seek new capital from new equity securities issuances that
will  provide funds needed to increase liquidity, fund internal growth and fully
implement  its  business  plan.


                                        6
<PAGE>
                          WEBMEDICALSERVICES.COM, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                        NOTES TO THE FINANCIAL STATEMENTS
                                DECEMBER 31, 1999

NOTE  2 - SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)

Cash  and  Cash  Equivalents
----------------------------

The  Company  has  only  a  demand  deposit  account.  It  does  not  have  cash
equivalents  at  this  time.

Accounting  Method
------------------

The  Company's  financial  statements  are  prepared using the accrual method of
accounting.  WebMedicalServices.com,  Inc.'s  year-end  is  December  31.

Basic  and  Diluted  Loss  Per  share
-------------------------------------

The  Company  has  adopted Statement of Financial Accounting Standards Statement
(SFAS)  No. 128, Earnings Per Share.  Basic earnings per share is computed using
the  weighted average number of common shares outstanding.  Diluted net loss per
share  is  the  same  as  basic  net loss per share as there are no common stock
equivalents  to  be  included  in  the  calculation.

Income  Taxes
-------------

No  provision  for  taxes  or  tax  benefit  has  been reported in the financial
statements,  as  there  is not a measurable means of assessing future profits or
losses.

Year  2000  Issues
------------------

Like  other  companies, WebMedicalServices.com, Inc. could be adversely affected
if  the  computer  systems  the  Company,  its suppliers or customers use do not
properly process and calculate date-related information and data from the period
surrounding  and including January 1, 2000.  This is commonly known as the "Year
2000"  issue.  Additionally,  this  issue  could impact non-computer systems and
devices  such  as  production  equipment  and elevators, etc.  At this time, the
Company  does  not  have  any evidence of problems associated with the year 2000
issue.

The  Company  has not purchased any software or hardware.  When the Company does
purchase software and hardware, it will determine at that time if there could be
any  adverse  effects  to  the  Company's operations regarding Year 2000 issues.
Management  also  believes that Year 2000 issues should not adversely affect the
ability  of its clients and customers to conduct business with the Company.  Any
costs  associated  with  Year  2000  compliance  will be expensed when incurred.

Impaired  Asset  Policy
-----------------------
The  Company  expects  to review any long-lived assets quarterly to determine if
any  events  or changes in circumstances have transpired which indicate that the
carrying value of its assets may not be recoverable in accordance with standards
in  SFAS  No.  121.


                                        7
<PAGE>
                          WEBMEDICALSERVICES.COM, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                        NOTES TO THE FINANCIAL STATEMENTS
                                DECEMBER 31, 1999

NOTE  3 - PROPERTY  AND  EQUIPMENT

At  December  31, 1999 the Company does not own any property or equipment.  When
the Company does acquire property and equipment it expects to implement a policy
to  determine  impairment  by  comparing  the  undiscounted  future  cash  flows
estimated  to be generated by those assets to their respective carrying amounts.

NOTE  4 - ACCOUNTS  RECEIVABLE  FROM  STOCKHOLDER

At December 31, 1999, the Company has a receivable from its president, the major
stockholder,  in  the  amount of $10,000.  This receivable arose from a contract
signed  by  the  president  with  an  advisory  firm  designated  to  assist  in
establishing  an  initial  public offering for the Company.  The total amount of
advisory  services  of  $55,000, of which $45,000 has been expensed to date, was
recorded  as  payment  for  the  issuance  of  common  stock.  See  Note  6.

NOTE  5 - COMMON  STOCK

Upon  incorporation, the Company authorized the issuance of 50,000,000 shares of
common  stock at a par value of $0.0001 per share of which 20,000,000 shares are
outstanding.  Holders  of  shares  of  common stock are entitled to one vote for
each  share  on  all  matters  to  be  voted on by the stockholders, but have no
cumulative  voting  rights.  Holders  of  shares of common stock are entitled to
share ratably in dividends, if any, as may be declared by the Board of Directors
in  its  discretion, from funds legally available therefor.  The Company has not
authorized  any  preferred  stock,  convertible stock, warrants or options as of
December  31,  1999.

The president and director of the Company, Dr. Burton Feinerman, owns 90% of the
outstanding  common  stock.

NOTE  6 - RELATED  PARTY

The  Company  issued  1,300,000  shares  of  common stock to companies under the
control  of  its  key  business  consultant, J. Thomas Howard LTD., at $.001 per
common  share.

The  Company  issued stock to the president in exchange for professional fees to
be  paid  by  the  president in the amount of $55,000, of which $45,000 has been
paid  to  date.  See Note 4.  The professional fees were due to J. Thomas Howard
LTD.,  which  contracted to provide services related to the initial registration
of  the  Company  under  the  Securities  Act of 1934.  The voting rights of the
shares  related  to  this transaction are held by J. Thomas Howard LTD until the
liability  is  satisfied.


                                        8
<PAGE>
                                    EXHIBITS

Exhibit  3.
     Articles of Incorporation incorporated by reference to Form 10SB12(g) filed
     December  17,  1999
     Bylaws  incorporated by reference to Form 10SB12(g) filed December 17, 1999

Exhibit  27
     Financial  Data  Schedule


<PAGE>
                                 SIGNATURE PAGE


        In  accordance  with  Section  13  or  15(d)  of  the  Exchange Act, the
registrant  caused  this  report  to be signed on its behalf by the undersigned,
thereunto  duly  authorized.

WEBMEDICALSERVICES.COM,  INC.

By  /S/  Dr.  Burton  Feinerman,  President

4/13/00

In  accordance  with  the Exchange Act, this report has been signed below by the
following  persons  on behalf of the registrant and in the capacities and on the
dates  indicated.

By  /S/  Dr.  Burton  Feinerman,  President,  Secretary,  Treasurer,  Director

4/13/00


<PAGE>